Landmark endTB-Q Trial Results on Hard-to-Treat form of TB Published in The Lancet Respiratory Medicine
On 16 July 2025, The Lancet Respiratory Medicine published the results of the Phase III endTB‑Q study, the first clinical trial to focus exclusively on pre‑extensively drug‑resistant tuberculosis (pre‑XDR‑TB).